Market
Overview:
The global Digital Diabetes Management Market predicted to witness striking CAGR of
23.7% during the forecast period from 2018 to 2023. This
growth in the coming years is predicted on the back of increasing inclination
toward the advanced health management systems coupled with large pool of
diabetic people. In addition to this, the factors such as increasing demand for
self-care, rising geriatric population, favorable reimbursement policies, and
government initiative for raising awareness are driving growth of the global
digital diabetes management market.
The
growing demand for home care among diabetics is likely to be the major driver for
the global digital diabetes management market over the forecast period.
Diabetes is a disease that doesn’t require a hospital stay for monitoring,
especially with the availability of modern tracking devices. This has led to a
growing demand for home care, as diabetes can be easily tracked and managed by
the patient or relatives of the patient from the confines of their household.
The growing prevalence of diabetes among the geriatric demographic has also
been a key driver for the global digital diabetes management market, as
geriatric individuals often prefer home care over hospital visits, which may be
taxing for their frail physique. This is likely to be a major driver for the
global digital diabetes management market over the forecast period.
Competitive
Analysis:
·
Abbott Laboratories
·
Agamatrix
·
B. Braun Melsungen AG
·
Dexcom
·
Dariohealth Corporation
·
F. Hoffmann-La Roche
·
Insulet Corporation
·
Glooko
·
Lifescan
·
Tandem Diabetes Care
·
Medtronic PLC
·
Tidepool
Segmentation:
The
global digital diabetes management market is segmented on the basis of product
and services, type, end user, and region.
By
type, the market is segmented into wearable devices and handheld devices.
By
product and Service, the market is segmented into digital diabetes management
apps, data management software and platforms, and services. Of these, data
management software and platforms segment is segmented into smart insulin pens,
devices smart glucose meters, continuous glucose monitoring systems, smart
insulin pumps/closed loop systems, and smart insulin patches. The digital
diabetes management apps segment is further sub-segmented into weight &
diet management apps and diabetes & blood glucose tracking apps.
By
end user, the market is segmented into hospitals & specialty diabetes
clinics, homecare, academic & research institutes, and others.
Regional
Analysis:
The Americas are the largest
digital diabetes management market, followed by Europe. Asia Pacific is
expected to exhibit the fastest growth in the coming years.
Industry
News:
In
2019, One Drop announced that the company is developing a diabetes management
system and soon will enter into the market with advanced technology for
diabetes management system which also provide accurate level of blood glucose.
In
2019, Omada Health and Blue Cross and Blue Shield of Minnesota announced the
availability of Omada's Type 2 Diabetes Digital Care program. This diabetes
program will be introduced for Minnesota employers in beginning January 2020.
No comments:
Post a Comment